期刊文献+

血浆脂蛋白磷脂酶A_2水平在急性动脉硬化性脑梗死患者中的变化 被引量:8

The Changes and Clinical Value of Plasma Lipoprotein Phospholipase A_2 Level in Patients with Acute Arteriosclerosis Cerebral Infarction
下载PDF
导出
摘要 目的探讨分析血浆脂蛋白磷脂酶A_2(LP-PLA_2)水平在急性动脉硬化性脑梗死患者中的变化及临床价值。方法选取115例急性动脉硬化性脑梗死患者,同时选取60例对照组患者,比较两组患者LP-PLA_2水平以及不同梗死面积、不同神经功能缺损程度患者LP-PLA_2水平的变化,并分析LP-PLA_2水平与患者年龄、性别、体质指数(BMI)、吸烟、收缩压(SBP)、舒张压(DBP)、血清总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)及C反应蛋白(CRP)之间的相关性。结果病例组患者的LP-PLA_2水平较对照组人群显著提高,大面积梗死的患者LP-PLA_2水平较小面积梗死的患者显著提高,不同程度神经功能缺损的患者LP-PLA_2水平差异具有统计学意义(P<0.05),进一步分析,随着患者神经功能缺损程度的加重,LP-PLA_2水平逐渐升高,患者性别、吸烟、SBP、DBP、CRP与患者的LP-PLA_2水平无显著性相关(P>0.05),患者年龄、BMI、TC、TG、LDL-C与LP-PLA_2水平呈正相关(P<0.05),患者的HDL-C与LP-PLA_2水平具有显著性负相关(P<0.05)。结论 LP-PLA_2与急性动脉硬化性脑梗死患者的梗死功能面积、神经功能缺损程度及生化指标密切相关,通过测定急性动脉硬化性脑梗死患者的LP-PLA_2能够预测疾病的发展,具有一定的临床价值。 Objective To analyze the changes and clinical value of plasma lipotrotein phospholipase A2 level ( LP-PLA2 ) in pa-tients with acute arteriosclerosis cerebral infarction ( ACI ) . Methods 115 cases with acute ACI were selected as the observation group, and 60 other cases were selected as the control group. The LP-PLA2 levels in two groups were compared and the changes of LP-PLA2 levels in patients with different infarct sizes and different degrees of neurological deficits were compared. In addition, the corre-lation of LP-PLA2 levels with patients’ age, sex, body mass index ( BMI) , smoking, systolic blood pressure ( SBP) , diastolic blood pressure ( DBP) , total cholesterol ( TC) , triglyceride ( TG) , high density lipoprotein cholesterol ( HDL-C) , low density lipoprotein cholesterol ( LDL-C) and C-reactive protein ( CRP) was analyzed. Results Compared with the control group, the LP-PLA2 level of the observation group increased significantly. LP-PLA2 level in patients with large infarcts increased significantly compared with that in patients with smaller infarct size. The differences in LP-PLA2 level among patients with varying degrees of neurological impairment were of statistical significance (P〈0. 05). To be further, LP-PLA2 level gradually increased as patientsˊneurological impairment ag-gravated. Patients’ LP-PLA2 level had no significant correlation with patients’ sex, smoking, SBP, DBP and CRP (P〉0. 05) and it had positive correlation with patients’ age, BMI, TC, TG and LDL-C (P〈0. 05). Patients’ HDL-C was in negative correlation with LP-PLA2 level (P〈0. 05). Conclusion LP-PLA2 is closely related to the infarct size, the degree of neurological deficit and biochemi-cal indexes of patients with acute arteriosclerosis cerebral infarction. By measuring LP-PLA2 level of patients with acute arteriosclerosis cerebral infarction, the development of the disease can be predicted. Therefore, it has certain clinical values.
出处 《辽宁医学院学报》 CAS 2016年第6期47-49,共3页 Journal of Liaoning Medical University (LNMU) Bimonthly
关键词 血浆脂蛋白磷脂酶A2 急性动脉硬化性脑梗死 临床价值 plasma lipoprotein phospholipase A2 acute atheroselerois cerebral infarction clinical values
  • 相关文献

参考文献5

二级参考文献33

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33009
  • 2Garza CA, Montori VM, McConnell JP, et al. Association be tween lipoprotein-associated phospholipase A2 and cardiovas cular disease: A systematic review. Mayo Clin Proceedings 2007,82:159-165.
  • 3Oei H H, vander Meer IM, Hofman A, et al. Lipoprotein-associ ated phospholipase A2 activity is associated with risk of coro nary heart disease and ischemic stroke: the Rotterdam Study Circulation,2005,111:570-575.
  • 4Winkler K, Winkelmann BR, Scharnagl H, et al. Platelet acti vating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors;The Ludwigshafen Risk and Cardiovascular Health Study. Circulation, 2005,111 ; 980-987.
  • 5陈灏珠,林果为等.实用内科学第13版[M].北京:人民卫生出版社,2009.9:1494.1495.
  • 6Leach C A,Hickey D M,Ife R J,et al.Lipoprotein-associated PLA2 inhibition-a novel,nonlipid lowering strategy for atherosclerosis therapy.[J].Farmaco Jan,2001,56(1-2):45-50.
  • 7Oei H H,Sayed-Tabatabaei F A,Hofman A,et al.The association between angiotensin-converting enzyme gene polymorphism and-coronary calcification.The Rotterdam Coronary Calcification Study[J].Atherosclerosis,2005,182 (1):169-173.
  • 8The Lp-PLA2 Studies Collaboration,Ballantyne C,Cushman M,et al.Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases[J].Eul J Cardiovasc Prev Rehabil,2007,14(1):3-11.
  • 9Ballantyne C M,Hoogeveen R C,Bang H,et al.lipoprotein-associated phospholipase A2,high-sensitivity C-reactive protein,and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study[J].Circulation,2004,109(7):837-842.
  • 10Rodriguez-Colon S M,Mo J,Duan Y,et al.Metabolic syndrome clusters and the risk of incident stroke; the atherosclerosis risk in communities (ARIC) study[J].Stroke,2009,40(1):200-205.

共引文献33039

同被引文献55

引证文献8

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部